Oman vs Tonga: New cases tested for RR-/MDR-TB

Oman
100.0%
in 2024
Tonga
100.0%
in 2023
Oman rank
1st
Tonga rank
1st

New cases tested for RR-/MDR-TB over time

  • Oman
  • Tonga
020406080100200520142024

How they compare

Oman currently reports 100.0% against 100.0% in Tonga, a difference of 0.0%.

The two have swapped places 1 time across 14 shared years of data; in 2010 it was Oman ahead.

Oman ranks 1st and Tonga ranks 1st of 192 countries.

Across the 2 decades both report, Oman averaged higher in 1 and Tonga in 1.

Head to head by decade

Decade Oman Tonga Difference Ahead
2010s 95.9% 30.0% 65.9% Oman
2020s 89.0% 100.0% 11.0% Tonga

Averages of every year both report within each decade.

Frequently asked questions

Which has higher new cases tested for rr-/mdr-tb, Oman or Tonga?
Oman, at 100.0% against 100.0% in Tonga as of 2024.
What is the difference in new cases tested for rr-/mdr-tb between Oman and Tonga?
0.0%, with Oman ahead.
How many years of comparable data are there for Oman and Tonga?
14 years are reported by both, from 2010 to 2023.
How do Oman and Tonga rank globally for new cases tested for rr-/mdr-tb?
Oman ranks 1st and Tonga ranks 1st of 192 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Oman vs Tonga: New cases tested for RR-/MDR-TB. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 25 August 2026, from https://health.statizoid.com/compare/new-cases-tested-for-rr-mdr-tb-percent/oman/tonga/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/new-cases-tested-for-rr-mdr-tb-percent/oman/tonga/">Oman vs Tonga: New cases tested for RR-/MDR-TB</a> — Statizoid

About this data

Indicator
New cases tested for RR-/MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
204 places, 3,368 data points, 2005–2024
Last refreshed